The Medicine Maker | The Medicine Maker

Video: Building the Airplane While Flying It – with Jonny Wray

October 16, 2026

Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology

1 min read

Packaging

Making Clinical Trial Labels More Accessible

Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial information

Business & Trends

Hiring for What Comes Next

Biotech boards are looking beyond big names to find leaders with the experience and flexibility to handle the company’s next major challenge.

Cell & Gene

Three Targets, One CAR T Therapy

First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma

Cell & Gene

SRSF1 Gene Delivery Extends Lifespan in Aged Mice

An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of cellular aging without erasing cell identity

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

View Profile

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

View Profile

Musings from The Power List: Claudia Zylberberg

Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale

Read the article

All the latest Medicine Maker articles.

Drug Discovery Future of Pharma Interviews

Looking Beyond Symptoms in Psychiatric Drug Development

October 15, 2026

Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace

8 min read

Cell & Gene Research News

CRISPR Cuts Cholesterol for a Year

October 14, 2026

A single CRISPR infusion sustained reductions in LDL cholesterol and triglycerides for 12 months.

2 min read

Development & Clinical Cell & Gene Interviews Power List

Musings From the Power List: Jason Bock

October 14, 2026

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

12 min read

Cell & Gene Regulation & Standards Business & Trends

Bringing CAR T Closer to Home

October 13, 2026

CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models

7 min read

Cell & Gene Technology & Manufacturing

CRISPR-Based Delivery System Generates CAR T Cells In Vivo

October 13, 2026

A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models

3 min read

Cell & Gene Industry News

Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount

October 12, 2026

“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce

2 min read

Facilities & Equipment Business & Trends Industry News

This Month’s Manufacturing Moves

October 12, 2026

Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit

5 min read

Development & Clinical Biopharma Interviews Sitting Down With

Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith

October 12, 2026

SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next

8 min read

Drug Delivery Cell & Gene Industry News

Prula-cel Shows Early Promise in Lupus

October 8, 2026

Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy

2 min read

Development & Clinical Small Molecules Business & Trends Power List

The Staying Power of Small Molecules

October 8, 2026

We asked the 2026 Power List whether newer modalities have eclipsed small molecules – and where the traditional mainstay still wins

4 min read

Top Stories